# The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

> **NCT02443194** · PHASE3 · TERMINATED · sponsor: **michal roll** · enrollment: 50 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** duloxetine
- **DRUG:** PLACEBO

## Key facts

- **NCT ID:** NCT02443194
- **Lead sponsor:** michal roll
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** principle investigator decision due to many adverse events in patients
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02443194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02443194, "The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02443194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*